ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,977Medicare Part D Prescriptions Filled, Including Refills

Rank: 339 out of 4623

$734K Total Retail Price of All Prescriptions

Rank: 327 out of 4623

422 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

25% of this provider’s 422 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 8,411 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 822 422 S3 1 3
AMLODIPINE BESYLATE 519 428 2 5
LISINOPRIL 393 277 3 4
SIMVASTATIN 390 310 4 2
LEVOTHYROXINE SODIUM 337 255 5 1
OMEPRAZOLE 334 223 6 7
FUROSEMIDE 256 189 7 8
METFORMIN HCL 237 182 8 6
CARVEDILOL 229 126 9 25
LOSARTAN POTASSIUM 221 158 10 21
METOPROLOL SUCCINATE 217 157 11 13
GABAPENTIN 203 102 12 16
ATORVASTATIN CALCIUM 180 168 13 12
DIOVAN 163 117 14 39
NEXIUM 150 92 15 17
ISOSORBIDE MONONITRATE ER 139 109 16 60
RANITIDINE HCL 134 87 17 47
TAMSULOSIN HCL 124 114 18 29
PLAVIX 122 109 19 45
ADVAIR DISKUS 115 92 20 62
INSULIN SYRINGE 112 76 21 85
SERTRALINE HCL 112 82 21 26
TRAMADOL HCL 109 74 23 15
BISOPROLOL FUMARATE 105 93 24 231
TRAZODONE HCL 102 65 25 42
POTASSIUM CHLORIDE 99 74 26 14
NOVOLIN 70-30 99 67 26 153
CRESTOR 95 84 28 20
JANUVIA 90 61 29 52
ALENDRONATE SODIUM 89 76 30 22
CLOPIDOGREL 88 73 31 31
POLYETHYLENE GLYCOL 3350 88 64 31 91
MELOXICAM 87 67 33 27
FLUTICASONE PROPIONATE 87 46 33 32
METFORMIN HCL ER 85 68 35 51
AZITHROMYCIN 84 65 36 33
NAMENDA 83 79 37 36
TORSEMIDE 82 50 38 164
CYMBALTA 82 53 38 48
CITALOPRAM HBR 80 67 40 23
DONEPEZIL HCL 79 79 41 30
ETODOLAC 78 75 42 160
ZOLPIDEM TARTRATE 73 31 43 18
CIPROFLOXACIN HCL 68 52 44 43
GLIMEPIRIDE 67 50 45 38
PRAVASTATIN SODIUM 66 42 46 11
WARFARIN SODIUM 66 46 46 24
OXYBUTYNIN CHLORIDE 65 27 48 120
GLIPIZIDE 63 53 49 49
DICYCLOMINE HCL 60 42 50 238
RISPERIDONE 60 47 50 72
PROMETHAZINE HCL 58 0 R 52 93
DIGOXIN 55 29 53 58
ALLOPURINOL 55 39 53 37
NITROSTAT 54 34 55 263
METOPROLOL TARTRATE 53 29 56 9
PAROXETINE HCL 52 24 57 78
RAMIPRIL 51 51 58 76
HUMULIN 70-30 50 12 59 202
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 12, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.